-
Hong Kong quality improvement model provides targeted care with results
During Saturday’s ADA Diabetes Care Symposium, Juliana CN Chan, MB, ChB, MD, FRCP, discussed how a research-driven quality improvement initiative in Hong Kong evolved to help reform the delivery of diabetes care in China.
-
Results from TrialNet, RISE, DECLARE-TIMI 58, and REWIND trials to be presented Sunday
Sunday will feature more highly anticipated study announcements than any other day of the 79th Scientific Sessions. Here’s an ADAMeetingNews.org preview of the the four Sunday sessions featuring major study results.
-
Q&A: Using advanced diabetes technology in older adults
The Centers for Medicare and Medicaid Services approved reimbursement for select continuous glucose monitoring (CGM) devices in 2017, but there are limited data on the use of CGM, insulin pumps, and other advanced diabetes technologies in older adults. Three clinical researchers, including Medha Munshi, MD, will share their insights, experience, and trial results during Sunday’s…
-
Behavioral economics used to improve patient engagement, promote healthy food choices
A panel of experts, including Jeffrey T. Kullgren, MS, MD, MPH, and Anne N. Thorndike, MD, MPH, will discuss ways to improve the effectiveness of diabetes interventions during Sunday’s symposium “Which Benefit Design and Behavioral Economic Interventions Can Be Used to Facilitate Diabetes Prevention?”
-
A mother’s diabetes may affect child’s neurobehaviors and cognitive function
Emerging data suggest that the offspring of mothers who have diabetes during pregnancy are at increased risk of cognitive and neurodevelopmental disorders. These mental effects are in addition to better-known metabolic risks associated with maternal diabetes, according to Anny Xiang, PhD, and Peter Damm, MD.
-
5 More Things about Sunday
Don’t forget to Wear Red Sunday to show your support of the ADA and our mission to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. And it’s not too late to register for Sunday morning’s 5K@ADA run/walk through San Francisco.
-
D2d Study: Vitamin D supplementation does not significantly reduce risk of type 2 diabetes
Among vitamin D-sufficient adults at high risk for type 2 diabetes, vitamin D supplementation at a dose of 4000 IU per day did not significantly lower the risk of diabetes compared to placebo, according to the results of the Vitamin D and Type 2 Diabetes (D2d) Study – A Multicenter Randomized Controlled Trial for Diabetes…
-
ADA/ACC joint symposium considers benefits of trials across specialties
Recent clinical trials studying the safety and efficacy of sodium-glucose co-transporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists in patients with diabetes have created opportunities for collaboration with cardiologists and nephrologists, according to Jean-François Yale, MD, FRCPC.
-
Experts debate benefits of aggressive lowering of LDL cholesterol
Sanket Dhruva, MD, MS, and Steven E. Nissen, MD, MACC, addressed the ongoing controversy about how intensive therapy should be to lower low-density lipoprotein (LDL) cholesterol during Friday’s session “Is Very Aggressive Lowering of LDL Cholesterol Worthwhile?”
-
Q&A: Evidence-based therapies for type 2 diabetes with CVD
Recent clinical trials are changing the evidence base clinicians use to select the most appropriate treatment for type 2 diabetes. Tina Vilsbøll, MD, DMSc, will discuss adding a GLP-1 receptor agonist to metformin during Saturday’s Current Issues session “Choosing Evidence-Based Therapy for Type 2 Diabetes Mellitus with Cardiovascular Disease.”